Second-line treatment option for children aged 18 years and under with an acute severe asthma exacerbation: a systematic review and meta-analysis of randomised controlled trials
{{output}}
Importance: Evidence regarding second-line treatment for severe asthma is limited. Objectives: To evaluate the safety and efficacy of intraveno... ...
